DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Pellicelli AM, Montalbano M, Lionetti R et al.
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late.
Digestive and liver disease – official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014;
46: 923-927
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.